Photosensitivity

 

Photosensitivity is a tendency to sunburn easily. Many drugs cause photosensitivity, including some chemotherapy drugs. Protecting your skin from the sun is very important. If you should get a severe sunburn, treatment is aimed at reducing inflammation and relieving pain.

What is photosensitivity?

Photosensitivity is an enhanced skin response to ultraviolet radiation (sunlight). This means that you may sunburn easily. A sunburn that you got within a week before chemotherapy may reappear, or rarely, a sunburn may spread to skin that was not exposed to the sun.

What causes photosensitivity?

There are many drugs that may cause photosensitivity. Chemotherapy drugs commonly associated with photosensitivity include:

  • DTIC-Dome® (dacarbazine)
  • 5-FU (fluorouracil)
  • Methotrexate
  • Velban® (vinblastine)
  • What are the symptoms of photosensitivity?

  • Symptoms of a sunburn include:
  • Redness
  • Inflammation
  • Blistering
  • Weeping
  • Peeling

What is the treatment for photosensitivity?

The treatments for a rash that results from photosensitivity aim to reduce inflammation and relieve pain.

Corticosteroid cream - Steroids work by reducing inflammation. Your doctor may prescribe a corticosteroid cream that you rub on the rash.

Analgesics - These over-the-counter medications can relieve pain associated with a rash. Examples are acetaminophen or aspirin.

What else can I do?

It is very important to protect your skin from the sun by following these tips:

  • Wear long sleeves and long pants.
  • Wear a wide brimmed hat.
  • Wear light, cotton gloves.
  • Use sunscreen on the skin that you cannot cover.
  • Sunblock with physical barrier such as zinc oxide may be necessary for vulnerable areas, such as the hands and nose.

For more information on having sensible fun in the sun, see Sun Sense.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health